Skip Navigation

This Article
Right arrow Print PDF (787K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (59)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Miles, J. S
Right arrow Articles by Wolf, C.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, J. S
Right arrow Articles by Wolf, C.R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1988, Vol. 16, No. 13 5783-5795
© 1988

Articles

A novel human cytochrome P4S0 gene (P450IIB): chromosomal localization and evidence for alternative splicing

John S Miles, Nigel K. Spurr1, Alan C. Gough1, Trevor Jowett2, Aileen W. McLaren, J.David Brook3 and C.Roland Wolf*

Imperial Cancer Research Fund, Laboratory of Molecular Pharmacology and Drug Metabolism, University Department of Biochemistry Hugh Robson Building, George Square, Edinburgh EH8 9XD 1Imperial Cancer Research Fund, Clare Hall Laboratories Blanche Lane, South Mimms, Potters Bar, Herts, EN6 3LD, UK 2Department of Genetics, University of Newcastle Newcastle Upon Tyne 3Institute of Medical Genetics, University of Wales College of Medicine Heath Park, Cardiff, UK

*To whom correspondence should be addressed

Received April 14, 1988. Revised June 1, 1988. Accepted June 1, 1988.

We have isolated from a single human liver cDNA library two clones which are highly homologous (78% over the coding region) to the major phenobarbital-inducible P450 from rat (P450IIB1). This is the first direct demonstration of the presence of the P450IIB gene subfamily in humans. This subfamily is much less extensive than the rodent homologues, but does appear to contain at least two genes. Of the cDNA clones isolated one is apparently normally spliced, whereas the other lacks exon 8 and retains all or part of intron 5. Both clones contain transcribed Alu sequences. The human P450IIB gene has been located to chromosome 19q12 19ql3.2 using a probe derived from intron 5, and is close to the CYP 2A locus encoding cytochrome P450IIA2. Restriction fragment length polymorphisms have been found with the enzymes BamHI and MSpI which will enable linkage to be determined between these two loci.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
V. Lamba, J. Lamba, K. Yasuda, S. Strom, J. Davila, M. L. Hancock, J. D. Fackenthal, P. K. Rogan, B. Ring, S. A. Wrighton, et al.
Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 906 - 922.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. A. Pampori and B. H. Shapiro
Nominal Growth Hormone Pulses in Otherwise Normal Masculine Plasma Profiles Induce Intron Retention of Overexpressed Hepatic CYP2C11 with Associated Nuclear Splicing Deficiency
Endocrinology, November 1, 2000; 141(11): 4100 - 4106.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. M. Stresser and D. Kupfer
Monospecific Antipeptide Antibody to Cytochrome P-450 2B6
Drug Metab. Dispos., April 1, 1999; 27(4): 517 - 525.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.